LAURA STERN: Open Payments
NPI 1336157460 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 17 payments from 9 companies in 2025. Trend: 2023 $150 · 2024 $166 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| JAZZ PHARMACEUTICALS INC. | 2 | $51 |
| Braeburn Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: CAPLYTA, XYWAV, BRIXADI, UZEDY, REXULTI, Sunosi, INGREZZA, INVEGA SUSTENNA.
Industry payments across NM — which companies pay providers there.
